SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-014205
Filing Date
2021-04-26
Accepted
2021-04-26 08:58:31
Documents
3
Period of Report
2021-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10023576_8k.htm 8-K 23018
2 EXHIBIT 99.1 brhc10023576_ex99-1.htm EX-99.1 10048
3 image00002.jpg GRAPHIC 2342
  Complete submission text file 0001140361-21-014205.txt   37648
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 21851868
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences